Ukrainian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Bolus Versus Continuous Enteral Tube Feeding

Тільки зареєстровані користувачі можуть перекладати статті
Увійти Зареєструватися
Посилання зберігається в буфері обміну
СтатусВербування
Спонсори
University Hospital Ostrava

Ключові слова

Анотація

Stress metabolisms induced by severe trauma, large abdominal surgery procedures, sepsis, etc. leads to metabolic changes, which increase energy expenditure, enhanced protein catabolism, insulin resistance. Muscle proteolysis is massively stimulated. Critically ill patients pay for survival with a loss of muscles. Enteral nutrition, especially protein delivery to critically ill, is very important for optimizing their outcome. Standard enteral feeding regiments are generally based on continuous feeding, which is thought to be better tolerated by critically ill patients with easier glycaemic control by continuous infusion of insulin, translated in less glycaemic variability. But this approach is not physiological, continuous feeding does not allow protein synthesis. Optimal protein synthesis requires a pulsatile increase in branched-chain amino acids. Bolus feeding activates the entrohormonal axis (bioactive peptides, insulin), and stimulates skeletal muscle synthesis to the maximum extent. The question is, whether bolus enteral feeding in critically ill patients with limited gastrointestinal function delivers a greater amount of protein, improves nutritional parameters, with higher quadriceps muscle layer thickness (QMLT) and muscle strength.

Опис

The trial has been designed in accordance with the Recommendations for Interventional Trials (SPIRIT 2013) and the Consolidated Standards for Reporting of Trials CONSORT guidelines.

Patients who meet the study inclusion criteria (severe trauma patients, surgical patients and medical patients with sepsis, with inserted nasogastric/nasoduodenal feed-ing tube) will be eligible to participate, especially patients who are mechanically ventilated. The last criterion is not a necessary precondition (a module of indirect calorimetry will be used in these patients). The necessary condition is the elimination of shock within 24 hours from the ICU admission and tolerance of trophic enteral feed-ing (20ml/hour) at for the period of at least 24 hours. Patients will be randomized in a ratio of 1:1 within 72 hours of their admission to receive bolus or continuous enteral feeding (sealed envelopes method). In both groups, the same goals of energy and protein will be observed (Day 1-2: E 15 kcal/kg/day, protein 0.8-1 g/kg/day; Day 3-4: E 20 kcal/kg/day, protein 1. 2 g/kg/day; Day ≥ 5: E 25 kcal/kg/day, protein 1.5-2 g/kg/day), according to protocol. The bolus enteral group will receive the amount of enteral nutrition in six boluses (per 60min dose), the continuous enteral group will receive the amount using a pump, within the timeframe of 6am-24pm. The need for parenteral nutrition will be determined by treating clinical staff independently to group allocation.

Demographic data collection: (weight, high, BMI) and conditions (trauma, surgical, medical patients), Acute Physiology and Chronic Health Evaluation (APACHE) Sequential Organ Failure Assessment (SOFA), Nutritional Risk Screening (NRS 2002).

Daily observations: glucose, mean glucose changes, insulin (IU/d), energy and protein intake (administered calories divided by the calculated energy expenditure and administered protein divided by calculated protein intake) - Adjusted/calculated energy and protein (%). Feeding intolerance (tolerating less than 40% of requirements via the enteral route for ≥ 3 days, diarrhea ≥ 500ml per day or five bowel actions). Mechanically ventilated patients (Resting Energy Expenditure (REE) and Respiratory Quotient (RQ) measured with indirect calorimetry) Day 1, 3, 5, 7: Nutritional parameters (serum albumin prealbumin, C-reactive protein (CRP), urine urea, N balance).

Day 1 and 7: Muscle layer thickness (QMLT by ultrasound measurement and mid-upper arm circumference) and muscle strength (dynamometer) from baseline to discharge. Outcomes of muscle strength/ultrasound and dynamometer) will be measured by an investigator blinded to the group allocation.

Дати

Востаннє перевірено: 08/31/2019
Перший поданий: 09/02/2019
Орієнтовна реєстрація подана: 09/02/2019
Опубліковано вперше: 09/05/2019
Останнє оновлення надіслано: 01/09/2020
Останнє оновлення опубліковано: 01/13/2020
Фактична дата початку навчання: 09/30/2019
Розрахункова дата первинного завершення: 09/29/2021
Розрахункова дата завершення дослідження: 12/30/2021

Стан або захворювання

Trauma Injury
Major Abdominal Surgery
Sepsis

Втручання / лікування

Diagnostic Test: Quadriceps Muscle Layer Fitness

Diagnostic Test: Muscle Strength

Diagnostic Test: Acute Physiology and Chronic Health Evaluation

Diagnostic Test: Sequential Organ Failure Assessment

Diagnostic Test: Nutritional Risk Screening

Diagnostic Test: Energy and Protein Intake

Фаза

-

Групи рук

РукаВтручання / лікування
Experimental: Bolus enteral feeding
The patients randomized into this study arm will receive bolus enteral feeding. The study subjects will undergo the following interventions: Quadriceps Muscle Layer Fitness measurement Muscle Strength measurement Acute Physiology and Chronic Health Evaluation Sequential Organ Failure Assessment Nutritional Risk Screening Energy and Protein Intake
Experimental: Continuous enteral feeding
The patients randomized into this study arm will receive bolus enteral feeding. The study subjects will undergo the following interventions: Quadriceps Muscle Layer Fitness measurement Muscle Strength measurement Acute Physiology and Chronic Health Evaluation Sequential Organ Failure Assessment Nutritional Risk Screening Energy and Protein Intake

Критерії прийнятності

Вік, придатний для навчання 18 Years До 18 Years
Стать, яка підходить для вивченняAll
Приймає здорових добровольцівТак
Критерії

Inclusion Criteria:

- polytrauma

- major abdominal surgery

- sepsis

- ICU stay

- enteral feeding tube

- artificial ventilation

Exclusion Criteria:

- contraindication of enteral feeding

- infaust prognosis

- prolonged shock (more than 24 hours)

Результат

Заходи первинного результату

1. Change in nutritional parameters - serum albumin [7 days]

The development of the serum albumin levels in g/dL will be observed.

2. Change in nutritional parameters - prealbumin [7 days]

The development of the serum albumin levels in mg/dL will be observed.

3. Change in inflammatory parameters - C-reactive protein (CRP) [7 days]

The development of inflammatory parameters in mg/L will be observed.

4. Change in muscle mass [7 days]

The development of muscle mass (circumference in centimetres) will be measured.

5. Change in muscle strength [7 days]

The development of muscle strength (in kilograms) will be measured.

Приєднуйтесь до нашої
сторінки у Facebook

Найповніша база даних про лікарські трави, підкріплена наукою

  • Працює 55 мовами
  • Лікування травами за підтримки науки
  • Розпізнавання трав за зображенням
  • Інтерактивна GPS-карта - позначайте трави на місці (скоро)
  • Читайте наукові публікації, пов’язані з вашим пошуком
  • Шукайте лікарські трави за їх впливом
  • Організуйте свої інтереси та будьте в курсі новинних досліджень, клінічних випробувань та патентів

Введіть симптом або хворобу та прочитайте про трави, які можуть допомогти, наберіть траву та ознайомтесь із захворюваннями та симптомами, проти яких вона застосовується.
* Вся інформація базується на опублікованих наукових дослідженнях

Google Play badgeApp Store badge